Literature DB >> 30877610

WDR34 Activates Wnt/Beta-Catenin Signaling in Hepatocellular Carcinoma.

Xiaoling Luo1, Yuting Liu2, Shijie Ma1, Lei Liu2, Rui Xie1, Shaochuang Wang3.   

Abstract

BACKGROUND: Wnt ligand binding initiates the interaction between Frizzled and Dvl proteins. However, the regulation of Frizzled-Dvl proteins interaction remains largely unknown. AIMS: The present study aims to elucidate the regulation of Frizzled-Dvl interaction by WDR34.
METHODS: The protein levels of WDR34 in hepatocellular carcinoma (HCC) tissues were examined by western blot and immunohistochemistry. The effects of WDR34 on the growth and migration of HCC cells were examined using MTT assay and Boyden chamber assay. The interaction between Frizzled and Dvl was evaluated by immunoprecipitation and GST pull-down assay.
RESULTS: In this study, we have shown that WDR34, the binding protein of Frizzled (Fz) activated beta-catenin/TCF signaling by enhancing the interaction between Fz and Dvl2. WDR34 was found to up-regulate in HCC tissues, and its expression was negatively correlated with the survival of HCC patients. WDR34 promoted the growth, colony formation and migration of HCC cells. However, knocking down the expression of WDR34 inhibited the growth, colony formation and migration of HCC cells.
CONCLUSION: Taken together, this study demonstrated the oncogenic roles of WDR34 in the progression of HCC and suggested that WDR34 might be a therapeutic target for HCC.

Entities:  

Keywords:  Beta-catenin/TCF signaling; Cell growth and migration; Hepatocellular carcinoma; WDR34

Year:  2019        PMID: 30877610     DOI: 10.1007/s10620-019-05583-w

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

Review 1.  Genetics of hepatocellular tumors.

Authors:  P Laurent-Puig; J Zucman-Rossi
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

2.  Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.

Authors:  J Zucman-Rossi; S Benhamouche; C Godard; S Boyault; G Grimber; C Balabaud; A S Cunha; P Bioulac-Sage; C Perret
Journal:  Oncogene       Date:  2006-09-11       Impact factor: 9.867

Review 3.  Wnt/β-catenin signalling in prostate cancer.

Authors:  Robert M Kypta; Jonathan Waxman
Journal:  Nat Rev Urol       Date:  2012-06-19       Impact factor: 14.432

4.  Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.

Authors:  Jik Young Park; Won Sang Park; Suk Woo Nam; Su Young Kim; Sug Hyung Lee; Nam Jin Yoo; Jung Young Lee; Cheol Keun Park
Journal:  Liver Int       Date:  2005-02       Impact factor: 5.828

5.  Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: cDNA microarray results.

Authors:  J Mares; M Szakacsova; V Soukup; J Duskova; A Horinek; M Babjuk
Journal:  Neoplasma       Date:  2013       Impact factor: 2.575

6.  Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.

Authors:  Ken Taniguchi; Lewis R Roberts; Ileana N Aderca; Xiangyang Dong; Chiping Qian; Linda M Murphy; David M Nagorney; Lawrence J Burgart; Patrick C Roche; David I Smith; Julie A Ross; Wanguo Liu
Journal:  Oncogene       Date:  2002-07-18       Impact factor: 9.867

7.  [Expression and exon 3 mutation of beta-catenin in human hepatocellular carcinoma].

Authors:  Yang Jiao; Ke-Chen Ban; Ji Cao; Hai-Ying Yue; Yuan Luo; Jian-Jia Su
Journal:  Ai Zheng       Date:  2007-10

Review 8.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

9.  Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.

Authors:  Young-Dae Kim; Chang-Hwan Park; Hyun-Soo Kim; Sung-Kyu Choi; Jong-Sun Rew; Dong-Yi Kim; Yang-Suk Koh; Kyung-Woon Jeung; Kyung-Hwa Lee; Ji-Shin Lee; Sang-Woo Juhng; Jae-Hyuk Lee
Journal:  J Gastroenterol Hepatol       Date:  2008-01       Impact factor: 4.029

10.  WDR34 is a novel TAK1-associated suppressor of the IL-1R/TLR3/TLR4-induced NF-kappaB activation pathway.

Authors:  Dong Gao; Ruipeng Wang; Bingfeng Li; Yongkang Yang; Zhonghe Zhai; Dan-Ying Chen
Journal:  Cell Mol Life Sci       Date:  2009-06-12       Impact factor: 9.261

View more
  3 in total

1.  WDR34 mutation from anencephaly patients impaired both SHH and PCP signaling pathways.

Authors:  Hailing Yin; Rui Peng; Zhongzhong Chen; Hongyan Wang; Ting Zhang; Yufang Zheng
Journal:  J Hum Genet       Date:  2020-06-23       Impact factor: 3.172

2.  Long non-coding RNA ROR1-AS1 induces tumorigenesis of colorectal cancer by affecting Wnt/β-catenin signaling pathway.

Authors:  Wei Wang; Weihong Zheng; Lei Zhang; Ke Li
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

3.  High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer.

Authors:  Xinkui Liu; Yang Wu; Yingying Zhang; Dechao Bu; Chao Wu; Shan Lu; Zhihong Huang; Yurong Song; Yi Zhao; Fengying Guo; Peizhi Ye; Changgeng Fu; Liangliang Shen; Jingyuan Zhang; Haojia Wang; Xianchun Duan; Jiarui Wu
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.